Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study

It has not yet been determined whether chronic exposure to relatively low doses of pioglitazone increases risk of bladder cancer. We aimed to assess the risk of bladder cancer associated with pioglitazone in Korean patients. This was a retrospective cohort study of diabetic patients who had ≥ 2 clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Sang-Man, Song, Sun Ok, Jung, Chang Hee, Chang, Jin-Sun, Suh, Sunghwan, Kang, Seung Min, Jung, Inkyung, Park, Cheol-Young, Kim, Jae Hyeon, Cho, Jae Hyoung, Lee, Byung-Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924003/
https://www.ncbi.nlm.nih.gov/pubmed/24550651
http://dx.doi.org/10.3346/jkms.2014.29.2.238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924003/
https://www.ncbi.nlm.nih.gov/pubmed/24550651
http://dx.doi.org/10.3346/jkms.2014.29.2.238

Ejemplares similares